Details

Reassessing lidocaine as an electroporation sensitizer in vitro
ID Blažič, Anja (Author), ID Šmerc, Rok (Author), ID Polajžer, Tamara (Author), ID Miklavčič, Damijan (Author)

.pdfPDF - Presentation file, Download (7,07 MB)
MD5: D744E32A8D8776AD6CEB930F8067A26C
URLURL - Source URL, Visit https://www.nature.com/articles/s41598-025-11695-3 This link opens in a new window

Abstract
High-intensity pulsed electric fields induce transient increase in membrane permeability, a phenomenon known as electroporation, with broad applications in medicine, including electrochemotherapy (ECT), gene electrotransfer and tissue ablation. As electroporation technologies become increasingly established in clinical practice, understanding how commonly used pharmacological agents influence treatment outcomes is gaining importance. Lidocaine, a widely used local anesthetic and ion channel modulator, has recently been investigated as a potential sensitizer to enhance the efficacy of electroporation. Here, we examined the effects of lidocaine on membrane permeabilization and cell viability using standard 8 × 100 µs ECT pulses across four cell lines: melanoma B16-F1, myoblast C2C12, CHO-K1 cells with low ion channel expression, and NS-HEK cells with stable ▫$Na_v$▫1.5 expression. We show that 10 mM lidocaine has only modest effects on electroporation outcomes, while 35 mM considerably lowers the electric field threshold for irreversible electroporation by 25–40% in melanoma cells. However, concentrations of even 10 mM exceed those reported in tissues following local administration of lidocaine. This questions the clinical relevance of lidocaine’s sensitization effect and warrants further investigation. Our study also highlights the importance of evaluating drug–electroporation interactions under rigorously controlled experimental conditions to ensure meaningful translation into clinical applications.

Language:English
Keywords:electroporation, sensitization, electropermeabilization, cell survival, lidocaione, melanoma cells
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FE - Faculty of Electrical Engineering
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:15 str.
Numbering:15, art. 25593
PID:20.500.12556/RUL-170893 This link opens in a new window
UDC:602.621
ISSN on article:2045-2322
DOI:10.1038/s41598-025-11695-3 This link opens in a new window
COBISS.SI-ID:243181571 This link opens in a new window
Publication date in RUL:21.07.2025
Views:201
Downloads:52
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Scientific reports
Shortened title:Sci. rep.
Publisher:Nature Publishing Group
ISSN:2045-2322
COBISS.SI-ID:18727432 This link opens in a new window

Secondary language

Language:Slovenian
Keywords:elektroporacija, senzitizacija, preživetje celic, lidokain, celice melanoma

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0249
Name:Elektroporacija v biologiji, biotehnologiji in medicini

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J2-2503
Name:Vpliv visokonapetostnih električnih pulzov na membranske proteine pri elektroporaciji

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young Researcher Program

Funder:EC - European Commission
Project number:893077
Name:Controlling the susceptibility of biological cells to pulsed electric field treatment by using ion channel modulators
Acronym:EPmIC

Funder:ARIS - Slovenian Research and Innovation Agency
Name:Electrical excitability of biological cells and tissues in silico (start-up research programme)

Funder:Other - Other funder or multiple funders
Funding programme:Medtronic

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:MN-0023-2024
Name:Controlling thesusceptibility of biologicalcells to pulsed electric fieldtreatment by using ionchannel modulators

Funder:EC - European Commission
Project number:101115323
Name:Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments
Acronym:REINCARNATION

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back